Print:
High-tech Manufacturing
- 12 manufacturing site of API, with US and EU cGMP compliance
- 25 manufacturing sites of finished dosage forms. State-of-the-art manufacturing equipments. Advanced manufacturing technologies of oral solid and lyophilized products.
- 31 billion RMB (about 150 million USD) investment.
-
Changshou Site(API)
-
Nan'an Site(FDF)
-
Chengdu Site(FDF)
-
Renhe Site(FDF)
